1 / 9

Global Neuroscience Antibodies & Assays Market, Forecast to 2023

Global neurobiology antibodies and assays market is anticipated to reach in USD 4.18 billion by 2023, at a CAGR of 10.2%. The report can facilitate the market leaders/new entrants during this market by providing them with the highest approximations of revenues for the general neurobiology antibodies and assays market and its subsegments.

bharatbookseo
Download Presentation

Global Neuroscience Antibodies & Assays Market, Forecast to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Neuroscience Antibodies & Assays Market, Forecast to 2023

  2. Summary • Growth during this market is driven by the rising incidence of neurologic diseases, increasing investments in neurobiology analysis, and growth within the pharmaceutical and biotechnology industries. • Global Neurobiology Antibodies and Assays Market is anticipated to reach in USD 4.18 billion by 2023, at a CAGR of 10.2%. • The report can facilitate the market leaders/new entrants during this market by providing them with the nighest approximations of revenues for the general neurobiology antibodies and assays market and its subsegments.

  3. Segmentation • NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, BY TECHNOLOGY • IMMUNOASSAYS/IMMUNOCHEMISTRY • MOLECULAR DIAGNOSTICS • CLINICAL CHEMISTRY • OTHER TECHNOLOGIES • NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET, BY APPLICATION • DRUG DISCOVERY & DEVELOPMENT • RESEARCH • IN VITRO DIAGNOSTICS

  4. Competitive Landscape • MARKET SHARE ANALYSIS, 2017 • COMPETITIVE SCENARIO • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2015–2018) • EXPANSIONS (2015–2018) • PRODUCT LAUNCHES (2015–2018) • ACQUISITIONS (2015–2018)

  5. Key Regions • NORTH AMERICA • EUROPE • ASIA • REST OF THE WORLD (ROW)

  6. Companies Profiled • Thermo Fisher Scientific (US) • Abcam (UK) • Bio-Rad (US) • Merck KGaA (Germany) • BioLegend (US) • Cell Signaling Technology (US) • F. Hoffmann-La Roche (Switzerland) • GenScript (China) • Rockland Immunochemicals (US) • Santa Cruz Biotechnology (US) • Siemens (Germany) • Tecan (Switzerland)

  7. Table of Contents • Introduction • Research Methodology • Executive Summary • Premium Insights • Market Overview • Neuroscience Antibodies And Assays Market, By Product • Neuroscience Antibodies And Assays Market, By Technology • Neuroscience Antibodies And Assays Market, By Application • Neuroscience Antibodies And Assays Market, By End User • Neuroscience Antibodies And Assays Market, By Region • Competitive Landscape • Company Profiles • Appendix

  8. View Reports Global Neuroscience Antibodies & Assays Market Contact us Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Email: poonam@bharatbook.com Follow us on

More Related